DKMA Update December 2018

Updated 23 January 2019

This newsletter features the following articles:


  • The safety of medical devices is strengthened

Latest news about medicines safety and medical devices

  • Further restrictions on the use of valproate
  • Risk of suicide to be reflected in the product information of contraceptive pills
  • Restricted use of antibiotics with quinolones and fluoroquinolones is advised
  • Stricter dose warning on the package of the arthritis and psoriasis medicine methotrexate
  • New biosimilar medicines for Humira

An insight into the work of the Danish Medicines Agency in 2018

  • New growth plan boosted the Danish Medicines Agency’s ambition to join Europe’s best in class
  • Danish Medicines Agency part of inspection agreement between EU and the USA in 2018
  • Concerted campaign on safe online shopping received with great interest
  • Impurities found in several batches of blood pressure lowing medicine valsartan
  • A Danish registry study found a small increased risk of two forms of cancer with the use of hydrochlorothiazide
  • High turnout for theme events at the Danish Medicines Agency
  • Tonnes seized in global operation against illegal online sale of medicines
  • Danish Medicines Agency strengthened its international collaboration
  • Danish Medicines Agency represented at World Economic Forum
  • Top marks for the Danish Medicines Agency in European survey
  • Danish Medicines Agency launched a new concept for national scientific advice
  • Work began on a new register of medicinal products to benefit patient safety
  • Major efforts for safer prescription of blood thinning medicines
  • Better conditions for clinical trials in Denmark
  • European top post for Thomas Senderovitz
  • Medicinal cannabis pilot programme entered into force

Two projects with focus on companies

  • Pharmaceutical companies must ensure people have access to package leaflets on
  • Major European review of the subdivision of tablets

Short news

  • New front page for our website
  • Brexit page on the website of the Danish Medicines Agency
  • Major international focus on the reporting of suspected adverse reactions
  • Thank you for your cooperation and dedication in 2018


DKMA Update December 2018 (pdf)

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.